Advertisement

Isolated Liver Perfusion for Hepatic Tumors

  • Karl J. Oldhafer
  • Hauke Lang
  • Rudolf Pichlmayr
Conference proceedings

Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 147)

Table of contents

  1. Front Matter
    Pages I-XI
  2. Indication

  3. Technique/Anaesthesia

    1. Front Matter
      Pages 17-17
    2. H. Lang, S. Nadalin, L. Moreno, A. Thyen, S. R. Shehata, P. Flemming et al.
      Pages 19-27
    3. Y. Nakajima, M. Horikawa, T. Kin, T. Ohyama, H. Kanehiro, M. Hisanaga et al.
      Pages 28-41
    4. K. J. Oldhafer, H. Lang, S. Nadalin, M. Frerker, W. Schüttler, A. Bornscheuer et al.
      Pages 42-50
    5. A. Bornscheuer, K. H. Mahr, K. Kirchhoff, K. J. Oldhafer, H. Lang, S. Piepenbrock
      Pages 56-64
  4. High-Dose Chemoperfusion

  5. Tumor Necrosis Factor

    1. Front Matter
      Pages 95-95
    2. N. P. Malek, J. Pluempe, S. Kubicka, M. P. Manns, C. Trautwein
      Pages 97-106
    3. M. R. de Vries, I. H. Borel Rinkes, C. J. H. van de Velde, T. Wiggers, R. A. E. M. Tollenaar, P. J. K. Kuppen et al.
      Pages 107-119
  6. Radiological Control of Tumor Response

  7. Future Aspects

    1. Front Matter
      Pages 155-155
    2. M. M. van der Eb, R. C. Hoeben, C. J. H. van de Velde
      Pages 173-186
  8. Back Matter
    Pages 187-193

About these proceedings

Introduction

The contributions in this book were originally presented at the workshop "Research and Clinical Application of Isolated Liver Perfusion for Hepatic Tumors" held on 28 February to 1 March 1997 in Hanover, Germany. The workshop was planned to bring together groups working with isolated liver perfusion techniques worldwide. Experts from various countries were invited to pre­ sent and discuss their experimental data and clinical results. USA par­ Groups from Japan, The Netherlands, Sweden and the ticipated. At the beginning, oncologists, surgeons and patholo­ gists presented possible indications and the oncological back­ ground for therapeutic isolated liver perfusion from their points of view. Based on data from previous studies about loco regional chemotherapy and based on the pathology of metastasis, it could be concluded that there is a place for isolated liver perfusion in the therapy of liver cancer. Second, different surgical techniques of isolated liver perfusion were presented. These techniques var­ ied from a percutaneous approach with extracorporeal chemofil­ tration to extended open abdominal surgery. Perfusion of the liv­ er without a considerable amount of drug reaching the systemic circulation proved to be possible. The complex procedure with complicated extracorporeal perfusion technique represented a disadvantage of the methods presented. Further studies should simplify the technical and surgical aspects. Intraoperative and postoperative management of . patients undergoing isolated liver perfusion were also discussed. Coagulopathy was one important aspect which can occur during isolated liver perfusion. The per­ centage of leakage determined systemic side effects.

Keywords

CT TNF Tumor cancer chemotherapy colorectal cancer computed tomography (CT) gene therapy hyperthermia liver liver tumor metastasis sonography surgery ultrasonography

Editors and affiliations

  • Karl J. Oldhafer
    • 1
  • Hauke Lang
    • 1
  • Rudolf Pichlmayr
    • 1
  1. 1.Klinik für Abdominal- und TransplantationschirurgieMedizinische Hochschule HannoverHannoverGermany

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-80460-1
  • Copyright Information Springer-Verlag Berlin Heidelberg 1998
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-80462-5
  • Online ISBN 978-3-642-80460-1
  • Series Print ISSN 0080-0015
  • Buy this book on publisher's site